KI-1125

N/A

Report date: 2022/05/10 11:41:02
NME

Base Information

Drug NameKI-1125
Drug Alias NameKI1125
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKuhnil Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperlipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A